News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 18, 2015

Do You Have the Right Doctor?

Episodes in this series

EP. 1 Understanding Prostate Cancer Grade and Stage

EP. 1 Understanding Prostate Cancer Grade and Stage

EP. 2 Getting a Second Opinion on Your Biopsy Report

EP. 2 Getting a Second Opinion on Your Biopsy Report

EP. 3 Prostate Cancer Staging

EP. 3 Prostate Cancer Staging

EP. 4 Multidisciplinary Care for Prostate Cancer

EP. 4 Multidisciplinary Care for Prostate Cancer

EP. 5 Patient With Metastatic Prostate Cancer

EP. 5 Patient With Metastatic Prostate Cancer

EP. 6 Patient With Locally Advanced Prostate Cancer

EP. 6 Patient With Locally Advanced Prostate Cancer

EP. 7 Reliable Information About Prostate Cancer

EP. 7 Reliable Information About Prostate Cancer

EP. 8 New Drugs for Advanced Prostate Cancer

EP. 8 New Drugs for Advanced Prostate Cancer

EP. 9 Do You Have the Right Doctor?

EP. 9 Do You Have the Right Doctor?

EP. 10 Prostate Cancer Awareness

EP. 10 Prostate Cancer Awareness

Newsletter

Stay up to date on cancer updates, research and education

Related Content

A real-world study found Erleada reduced the risk of death compared with darolutamide in patients with metastatic castration-sensitive prostate cancer: © stock.adobe.com.

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

February 2nd 2026

Brian Sluga is now a testicular cancer survivor after receiving the diagnosis when he was 20 years old. Catch up on Brian's blogs here!

Finding My Power of One After Cancer

January 19th 2026

Ronald Wakefield and Ernie Strauss

Advice From Two Prostate Cancer Survivors For Newly Diagnosed Patients

January 14th 2026

prostate cancer

FDA Fast Tracks Enolen For Localized Prostate Cancer Treatment

January 11th 2026

Ernie Strauss and Ronald Wakefield

Facing Misconceptions and Stigmas of Prostate Cancer Together

ByRonald Wakefield,Ernie Strauss

January 6th 2026

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

KTX-1001 Elicits Responses in Some With Multiple Myeloma

New Combination Treatment Approach Studied in Pancreatic Cancer

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma

Biomarker-Free Relacorilant Combo Broadens Options in Ovarian Cancer